Literature DB >> 2117119

Life in the allogeneic environment after lung transplantation.

I Paradis1, H Rabinowich, A Zeevi, S Yousem, B Noyes, R Hoffman, B Griffith, J Dauber.   

Abstract

Because infection and rejection are the principal complications of any transplant procedure and because the alveolar macrophage is crucial to the defense of the lung from infection and may play a role in lung allograft rejection, we have begun to assess functions of this cell that are thought to be important in lung defense from infection and in transplant immunity. Antimicrobial functions include chemotaxis, which is a mechanism for recruiting macrophages to sites of inflammation and phagocytosis, and intracellular killing of microorganisms. As an accessory cell, the alveolar macrophage is necessary for an effective immune response to develop against either microorganisms or transplantation antigens. Our results indicate that the chemotactic, phagocytic but not the killing capability of alveolar macrophages from lung recipients is impaired. Alveolar macrophages and blood monocytes from lung recipients are also significantly impaired in their support for mitogen and antigen presentation to lymphocytes. Thus, the generation of an effective immune response to a microorganism may be impaired. Alveolar macrophages from lung recipients, however, function as well as those from normal subjects in stimulating lymphocyte proliferation in response to donor antigens (primed lymphocyte test) or unrelated allogeneic antigens (mixed lymphocyte reaction), while their respective blood monocytes function poorly in this regard. Our conclusions are that the antimicrobial functions of the alveolar macrophages are impaired after lung transplantation and this may be one mechanism to explain the unusual susceptibility of the lung allograft to infection. Those functions related to transplant immunity, however, are preserved and indicate that the alveolar macrophage may play a role in allograft rejection.

Entities:  

Mesh:

Year:  1990        PMID: 2117119     DOI: 10.1007/bf02718259

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  30 in total

1.  Immunologically mediated disease of the airways after pulmonary transplantation.

Authors:  B P Griffith; I L Paradis; A Zeevi; H Rabinowich; S A Yousem; R J Duquesnoy; J H Dauber; R L Hardesty
Journal:  Ann Surg       Date:  1988-09       Impact factor: 12.969

2.  Alveolar macrophage stimulation of T-cell proliferation in autologous mixed lymphocyte reactions. Role of HLA-DR antigens.

Authors:  G A Rossi; E Zocchi; O Sacco; B Balbi; C Ravazzoni; G Damiani
Journal:  Am Rev Respir Dis       Date:  1986-01

3.  A 48-well micro chemotaxis assembly for rapid and accurate measurement of leukocyte migration.

Authors:  W Falk; R H Goodwin; E J Leonard
Journal:  J Immunol Methods       Date:  1980       Impact factor: 2.303

4.  Infections in heart-lung transplant recipients.

Authors:  J S Dummer; C G Montero; B P Griffith; R L Hardesty; I L Paradis; M Ho
Journal:  Transplantation       Date:  1986-06       Impact factor: 4.939

5.  Effect of cyclosporine on the antigen-presenting function of human and murine accessory cells.

Authors:  F Manca; D Fenoglio; A Kunkl; M Caltabellotta; F Celada
Journal:  Transplantation       Date:  1988-08       Impact factor: 4.939

6.  Infectious complications in heart transplant recipients receiving cyclosporine and corticosteroids.

Authors:  J M Hofflin; I Potasman; J C Baldwin; P E Oyer; E B Stinson; J S Remington
Journal:  Ann Intern Med       Date:  1987-02       Impact factor: 25.391

7.  Phenotype of the accessory cell necessary for mitogen-stimulated T and B cell responses in human peripheral blood: delineation by its sensitivity to the lysosomotropic agent, L-leucine methyl ester.

Authors:  D L Thiele; M Kurosaka; P E Lipsky
Journal:  J Immunol       Date:  1983-11       Impact factor: 5.422

8.  A rapid micro method for the simultaneous determination of phagocytic-microbiocidal activity of human peripheral blood leukocytes in vitro.

Authors:  D L Smith; F Rommel
Journal:  J Immunol Methods       Date:  1977       Impact factor: 2.303

9.  Morbidity of cytomegalovirus infection in recipients of heart or heart-lung transplants who received cyclosporine.

Authors:  J S Dummer; L T White; M Ho; B P Griffith; R L Hardesty; H T Bahnson
Journal:  J Infect Dis       Date:  1985-12       Impact factor: 5.226

10.  Early infections in kidney, heart, and liver transplant recipients on cyclosporine.

Authors:  J S Dummer; A Hardy; A Poorsattar; M Ho
Journal:  Transplantation       Date:  1983-09       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.